Understanding how different malaria-carrying mosquitoes affect treatment strategies
Impact of malaria vector diversity on intervention strategies
This study looks at the different types of mosquitoes that spread malaria in Malawi and how these differences affect how well malaria treatments work, with the goal of finding better ways to control the disease.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10897880 on NIH RePORTER |
What this research studies
This research investigates the diversity of malaria-carrying mosquitoes in Malawi and how this diversity impacts the effectiveness of malaria interventions. The study combines fieldwork and laboratory experiments to analyze the competence of key mosquito species and uses advanced computational models to predict how variations in mosquito susceptibility influence treatment outcomes. By examining genetic relationships and migration patterns of these vectors, the research aims to provide insights that could enhance malaria control strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in malaria-endemic regions of Malawi, particularly those affected by malaria transmission.
Not a fit: Patients living outside of malaria-endemic areas or those not affected by malaria will likely not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective malaria prevention and treatment strategies tailored to specific mosquito populations.
How similar studies have performed: Previous research has shown that understanding vector diversity can significantly improve malaria control efforts, indicating that this approach has potential for success.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Mccann, Robert Sean — University of Maryland Baltimore
- Study coordinator: Mccann, Robert Sean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.